Year: 2009

New patent application

  • 11:01

Immunicum submits a provisional patent application, METHOD FOR PROLIFERATION OF ANTIGEN-SPECIFIC T CELLS, to the USPTO (application number: 61/255,146) and… Read more

Park Annual 2009

  • 11:09

Immunicum’s CEO, Jamal El-Mosleh, holds a company presentation at Park Annual 09.

UK-Nordic Oncology Conference

  • 11:11

Immunicum’s CEO, Jamal El-Mosleh, holds a company presentation at UK-Nordic Oncology Conference in Copenhagen.